Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
by Si Fang, James Yarmolinsky, Dipender Gill, Caroline J. Bull, Claire M. Perks, the PRACTICAL Consortium , George Davey Smith, Tom R. Gaunt, Tom G. Richardson
Читать дальше...